Sculptor Capital LP Atossa Therapeutics, Inc. Transaction History

Sculptor Capital LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 13, 2022	SELL	$1.11 - $1.74 $238,095 - $373,230	-214,500 Closed	0 $0
Q3 2021 Nov 12, 2021	SELL	$2.89 - $6.4 $154,615 - $342,400	-53,500 Reduced 19.96%	214,500 $699,000
Q2 2021 Aug 16, 2021	BUY	$1.52 - $8.62 $326,040 - $1.85 Million	214,500 Added 400.93%	268,000 $1.69 Million
Q1 2021 May 14, 2021	BUY	$0.92 - $4.33 $49,220 - $231,655	53,500 New	53,500 $113,000

26.5M

466K

91.8K

Ticker ATOS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 126,624,000
Market Cap $130M
Description
Atossa Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of medicines in the areas of oncology and infectious diseases. The company's lead program is Endoxifen, an active metabolite of tamoxifen, which is in Phase II clinical trials to treat and prevent breast cancer. It is also developing A...

Get notified when there are updates to the investment portfolio of Sculptor Capital LP, based on Form 13F filings with the SEC.

Stay updated on Sculptor Capital LP with notifications on news.